Dr. Aaron Kesselheim talks with CBS Boston, Medpage Today, The Los Angeles Times, The Washington Post, The Wall Street Journal, and The Boston Globe about a study he conducted that found that when patients received a generic drug that differed in shape or color from their previous one, they were more likely to stop filling it.
Faculty Web Pages
- Division members launch the website for the Harvard Program on Perinatal and Pediatric Pharmacoepidemiology (H4P)
- DoPE Annual Report 2016
- Dr. Mike Fralick discusses a recent Big Data study on The Rounds Table
- Ameet Sarpatwari discusses the misuse of drug distribution schemes to forestall generic competition in the New York Times, AP, and Chemical and Engineering News
- NEJM Catalyst Free Live Web Event: Niteesh Choudhry to present, lead discussion, and share perspectives on quality and health care improvements through patient engagement
- Thomson Reuters: Avorn, Glynn, and Schneeweiss named to 2015 Highly Cited Researcher list